Gregory L. Verdine's most recent trade in Wave Life Sciences Ltd. was a trade of 12,020 Ordinary Shares done at an average price of $13.1 . Disclosure was reported to the exchange on Dec. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Sale of securities on an exchange or to another person at price $ 13.09 per share. | 08 Dec 2025 | 12,020 | 283,197 (0%) | 0% | 13.1 | 157,342 | Ordinary Shares |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Sale of securities on an exchange or to another person at price $ 14.05 per share. | 08 Dec 2025 | 7,980 | 275,217 (0%) | 0% | 14.1 | 112,119 | Ordinary Shares |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 22 Aug 2025 | 10,000 | 285,217 (0%) | 0% | 10 | 100,000 | Ordinary Shares |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2025 | 76,200 | 76,200 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2025 | 12,700 | 295,217 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Sale of securities on an exchange or to another person at price $ 6.95 per share. | 13 Jun 2025 | 30,000 | 282,517 (0%) | 0% | 7.0 | 208,500 | Ordinary Shares |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 05 Mar 2025 | 133,402 | 312,517 (0%) | 0% | 2.5 | 330,837 | Ordinary Shares |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 133,402 | 0 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 133,000 | 133,402 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 05 Mar 2025 | 133,000 | 179,155 (0%) | 0% | 2.5 | 329,840 | Ordinary Shares |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 32,230 | 32,230 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 16,115 | 46,115 (0%) | 0% | 0 | Ordinary Shares | |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 45,000 | 45,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 21,000 | 21,000 | - | - | Share Option (right to buy) | |
| Wave Life Sciences Ltd | Gregory L. Verdine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 42,000 | 42,000 | - | - | Share Option (right to buy) |